CCND2 and megalencephaly: The mutated form of CCND2 present in MPPH patients induces a gain-of-function mutation of cyclin D2, meaning it remains stabilized during neural progenitor cell proliferation, which result in uncontrolled cell growth, leading to megalencephaly exhibited in these patients [283].